| RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E) PI Poulikakos, Y Persaud, M Janakiraman, X Kong, C Ng, G Moriceau, ... Nature 480 (7377), 387-390, 2011 | 1629 | 2011 |
| Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance H Shi, G Moriceau, X Kong, MK Lee, H Lee, RC Koya, C Ng, T Chodon, ... Nature communications 3 (1), 724, 2012 | 815 | 2012 |
| Focused specificity of intestinal TH17 cells towards commensal bacterial antigens Y Yang, MB Torchinsky, M Gobert, H Xiong, M Xu, JL Linehan, F Alonzo, ... Nature 510 (7503), 152-156, 2014 | 547 | 2014 |
| Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway M Atefi, E von Euw, N Attar, C Ng, C Chu, D Guo, R Nazarian, ... PloS one 6 (12), e28973, 2011 | 276 | 2011 |
| Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma T Chodon, B Comin-Anduix, B Chmielowski, RC Koya, Z Wu, M Auerbach, ... Clinical Cancer Research 20 (9), 2457-2465, 2014 | 263 | 2014 |
| Polymer nanofiber‐embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells S Hou, L Zhao, Q Shen, J Yu, C Ng, X Kong, D Wu, M Song, X Shi, X Xu, ... Angewandte Chemie 125 (12), 3463-3467, 2013 | 245 | 2013 |
| BRAF L597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors KB Dahlman, J Xia, K Hutchinson, C Ng, D Hucks, P Jia, M Atefi, Z Su, ... Cancer discovery 2 (9), 791-797, 2012 | 234 | 2012 |
| A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition H Shi, A Hong, X Kong, RC Koya, C Song, G Moriceau, W Hugo, CC Yu, ... Cancer discovery 4 (1), 69-79, 2014 | 183 | 2014 |
| Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy C Ma, AF Cheung, T Chodon, RC Koya, Z Wu, C Ng, E Avramis, ... Cancer discovery 3 (4), 418-429, 2013 | 150 | 2013 |
| Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations F Niehr, E von Euw, N Attar, D Guo, D Matsunaga, H Sazegar, C Ng, ... Journal of translational medicine 9, 1-13, 2011 | 114 | 2011 |
| Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines E von Euw, M Atefi, N Attar, C Chu, S Zachariah, BL Burgess, S Mok, C Ng, ... Molecular cancer 11, 1-9, 2012 | 90 | 2012 |
| Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy L Wu, KER Hollinshead, Y Hao, C Au, L Kroehling, C Ng, WY Lin, D Li, ... Cell 182 (3), 641-654. e20, 2020 | 85 | 2020 |
| Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma M Atefi, B Titz, E Avramis, C Ng, DJL Wong, A Lassen, M Cerniglia, ... Molecular cancer 14, 1-12, 2015 | 63 | 2015 |
| COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors H Escuin-Ordinas, M Atefi, Y Fu, A Cass, C Ng, RR Huang, S Yashar, ... Molecular oncology 8 (2), 250-260, 2014 | 53 | 2014 |
| Heritable gene regulation in the CD4: CD8 T cell lineage choice PDA Issuree, CP Ng, DR Littman Frontiers in immunology 8, 250073, 2017 | 39 | 2017 |
| SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling W Gu, H Wang, X Huang, J Kraiczy, PNP Singh, C Ng, S Dagdeviren, ... Cell Stem Cell 29 (1), 101-115. e10, 2022 | 37 | 2022 |
| Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes T Sano, T Kageyama, V Fang, R Kedmi, CS Martinez, J Talbot, A Chen, ... Cell reports 36 (8), 2021 | 27 | 2021 |
| The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain Cd4 silencing in cytotoxic T cells C Ng, M Aichinger, T Nguyen, C Au, T Najar, L Wu, KR Mesa, W Liao, ... Genes & Development 33 (11-12), 669-683, 2019 | 27 | 2019 |
| Lactate activates the mitochondrial electron transport chain independently of its metabolism X Cai, CP Ng, O Jones, TS Fung, KW Ryu, D Li, CB Thompson Molecular cell 83 (21), 3904-3920. e7, 2023 | 22 | 2023 |
| Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell–derived cytokines S Schwörer, FV Cimino, M Ros, KM Tsanov, C Ng, SW Lowe, ... Cancer research 83 (10), 1596-1610, 2023 | 20 | 2023 |
